| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |